Back
Highland Opportunities and Income Fund Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
44
HFRO
Highland Opportunities and Income Fund
Last Price:
$5.98
Seasonality Move:
-2.94%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.09
Seasonality Move:
12.13%
Sell
44
Highland Opportunities and Income Fund (HFRO)
is a Sell
Is Highland Opportunities and Income Fund a Buy, Sell or Hold?
-
The current Highland Opportunities and Income Fund [HFRO] share price is $6.08. The Score for HFRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
HFRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $785.17. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HFRO Stock Price Chart
What is Highland Opportunities and Income Fund's stock price today?
-
The Highland Opportunities and Income Fund share price today is $6.08Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HFRO is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $785.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
HFRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 45.23 | Sell |
| Chaikin Money Flow: | -117559 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6 - 6.18) | Sell |
| Bollinger Bands (100): | (5.96 - 6.52) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 190.52 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 31173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (719.04 - 771.48) | Buy |
| Bollinger Bands (100): | (554.73 - 705.63) | Buy |
HFRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.11 | Sell |
| 20-day SMA: | 6.1 | Sell |
| 50-day SMA: | 6.27 | Sell |
| 200-day SMA: | 5.68 | Buy |
| 8-day EMA: | 6.11 | Sell |
| 20-day EMA: | 6.13 | Sell |
| 50-day EMA: | 6.1 | Sell |
| 200-day EMA: | 3.99 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 758.91 | Buy |
| 20-day SMA: | 747.46 | Buy |
| 50-day SMA: | 686.87 | Buy |
| 200-day SMA: | 601.47 | Buy |
| 8-day EMA: | 551.68 | Buy |
| 20-day EMA: | 302.47 | Buy |
| 50-day EMA: | 139.05 | Buy |
| 200-day EMA: | 37.38 | Buy |
Highland Opportunities and Income Fund Earnings Growth & HFRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Highland Opportunities and Income Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||